TrialClinical and translational medicine2024

Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial.

Xiaochu Man et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.